Standard
A role for m6A RNA methylation in heart failure development? / on behalf of EU-CardioRNA COST Action CA17129.
I:
European Journal of Heart Failure, Bind 22, Nr. 1, 2020, s. 67-69.
Publikation: Bidrag til tidsskrift › Leder › Forskning › fagfællebedømt
Harvard
on behalf of EU-CardioRNA COST Action CA17129 2020, '
A role for m6A RNA methylation in heart failure development?',
European Journal of Heart Failure, bind 22, nr. 1, s. 67-69.
https://doi.org/10.1002/ejhf.1714APA
on behalf of EU-CardioRNA COST Action CA17129 (2020).
A role for m6A RNA methylation in heart failure development? European Journal of Heart Failure,
22(1), 67-69.
https://doi.org/10.1002/ejhf.1714Vancouver
on behalf of EU-CardioRNA COST Action CA17129.
A role for m6A RNA methylation in heart failure development? European Journal of Heart Failure. 2020;22(1):67-69.
https://doi.org/10.1002/ejhf.1714Author
on behalf of EU-CardioRNA COST Action CA17129. / A role for m6A RNA methylation in heart failure development?. I: European Journal of Heart Failure. 2020 ; Bind 22, Nr. 1. s. 67-69.
Bibtex
@article{1bac1225c84b4e2f967d908cf301fc85,
title = "A role for m6A RNA methylation in heart failure development?",
abstract = "This article refers to {\textquoteleft}Changes in m6A RNA methylation contribute to heart failure progression by modulating translation{\textquoteright} by T. Berulava et al., published in this issue on pages 54–66.",
author = "Yvan Devaux and Nossent, {Anne Ya{\"e}l} and {on behalf of EU-CardioRNA COST Action CA17129}",
note = "Funding Information: Dr. Devaux is Chair of the EU-CardioRNA COST ACTION CA17129 (www.cardiorna.eu), supported by COST (European Cooperation in Science and Technology). Dr. Devaux is supported by the National Research Fund of Luxembourg (grants # C14/BM/8225223 and C17/BM/11613033), the Ministry of Higher Education and Research of Luxembourg, and the Heart Foundation – Daniel Wagner. Dr Nossent is funded by a Lise Meitner grant (M2578-B30) of the Austrian Science Fund FWF. Conflict of interest: none declared. Funding Information: Dr. Devaux is Chair of the EU‐CardioRNA COST ACTION CA17129 ( www.cardiorna.eu ), supported by COST (European Cooperation in Science and Technology). Dr. Devaux is supported by the National Research Fund of Luxembourg (grants # C14/BM/8225223 and C17/BM/11613033), the Ministry of Higher Education and Research of Luxembourg, and the Heart Foundation – Daniel Wagner. Dr Nossent is funded by a Lise Meitner grant (M2578‐B30) of the Austrian Science Fund FWF. ",
year = "2020",
doi = "10.1002/ejhf.1714",
language = "English",
volume = "22",
pages = "67--69",
journal = "European Journal of Heart Failure",
issn = "1567-4215",
publisher = "JohnWiley & Sons Ltd",
number = "1",
}
RIS
TY - JOUR
T1 - A role for m6A RNA methylation in heart failure development?
AU - Devaux, Yvan
AU - Nossent, Anne Yaël
AU - on behalf of EU-CardioRNA COST Action CA17129
N1 - Funding Information:
Dr. Devaux is Chair of the EU-CardioRNA COST ACTION CA17129 (www.cardiorna.eu), supported by COST (European Cooperation in Science and Technology). Dr. Devaux is supported by the National Research Fund of Luxembourg (grants # C14/BM/8225223 and C17/BM/11613033), the Ministry of Higher Education and Research of Luxembourg, and the Heart Foundation – Daniel Wagner. Dr Nossent is funded by a Lise Meitner grant (M2578-B30) of the Austrian Science Fund FWF. Conflict of interest: none declared.
Funding Information:
Dr. Devaux is Chair of the EU‐CardioRNA COST ACTION CA17129 ( www.cardiorna.eu ), supported by COST (European Cooperation in Science and Technology). Dr. Devaux is supported by the National Research Fund of Luxembourg (grants # C14/BM/8225223 and C17/BM/11613033), the Ministry of Higher Education and Research of Luxembourg, and the Heart Foundation – Daniel Wagner. Dr Nossent is funded by a Lise Meitner grant (M2578‐B30) of the Austrian Science Fund FWF.
PY - 2020
Y1 - 2020
N2 - This article refers to ‘Changes in m6A RNA methylation contribute to heart failure progression by modulating translation’ by T. Berulava et al., published in this issue on pages 54–66.
AB - This article refers to ‘Changes in m6A RNA methylation contribute to heart failure progression by modulating translation’ by T. Berulava et al., published in this issue on pages 54–66.
U2 - 10.1002/ejhf.1714
DO - 10.1002/ejhf.1714
M3 - Editorial
C2 - 31867852
AN - SCOPUS:85076892949
VL - 22
SP - 67
EP - 69
JO - European Journal of Heart Failure
JF - European Journal of Heart Failure
SN - 1567-4215
IS - 1
ER -
